Evidence map›Paper›PMID 26912552›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2016

Rethinking First-Line Immunosuppression for Idiopathic FSGS.

Jordana B Cohen, Jonathan J Hogan

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jordana B CohenRenal, Electrolyte, and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania jco@mail.med.upenn.edu.
Jonathan J HoganRenal, Electrolyte, and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

Obesity, renin-angiotensin-aldosterone blockade, and chronic kidney diseaseF32DK103484 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI COHEN, JORDANA B. · 2014 to 2015
$145k
NIDDK NIH HHS F32 DK103484NIDDK NIH HHS F32DK103484
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Glomerulosclerosis, Focal SegmentalImmunosuppression TherapyHumansImmune ToleranceKidney Glomerulusfocal segmental glomerulosclerosisglomerular diseaseImmune Toleranceimmunosuppressiontreatment

Identifiers

PMID26912552
PMCPMC4791829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.